Mustafa Çolak

Dr. Mustafa Çolak


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2024 in Tuberk Toraks
Verified
Journal Article
Open access
MÇMustafa Çolak
Mustafa Çolak
HÇHikmet Çoban
Hikmet Çoban
NSNurhan Sarioglu
Nurhan Sarioglu
MŞMerve Yumrukuz Şenel
Merve Yumrukuz Şenel
FEFuat Erel
Fuat Erel
Bronchiectasis is a chronic inflammatory lung disease and patients may occasionally experience acute exacerbations. Our study aims to determine the relationship between exacerbation periods and HALP (hemoglobin, albumin, lymphocyte, platelet) scores in patients with bronchiectasis. Adult patients diagnosed with bronchiectasis and followed up in our clinic between 02.2020-12.2022 were retrospectively evaluated. After the examinations, the effect of bronchiectasis exacerbation on the HALP score was investigated. A total of 84 patients diagnosed with non-cystic fibrosis bronchiectasis were included in our study. 42 of the patients were male (50%), and 42 were female. The average age of all patients was 52.37 ± 16.2. 35 patients (41.7%) were in the exacerbation period, and 49 patients (58.3%) were in the stable period. The median values of leukocytes, neutrophils, and C-reactive protein (CRP) were significantly higher in patients during the exacerbation period compared to the stable period (respectively p= 0.00, p= 0.00, p= 0.00). The average values of FEV1% and FVC% in patients during the exacerbation period were significantly lower compared to the stable period (p= 0.03, p= 0.00, respectively). The HALP score was significantly lower in patients during the exacerbation period compared to the stable period (p= 0.00). A significant negative correlation was found between the HALP score and leukocytes, neutrophils, and CRP (p= 0.00, p= 0.00, p= 0.00, respectively). Also, a significant positive correlation was found between the HALP score and FEV1% and FVC% (p= 0.00, p= 0.00, respectively). Our study revealed that the HALP score is associated with infectious and pulmonary functional parameters in bronchiectasis patients in the exacerbation period. We propose that the HALP score could serve as a valuable biomarker during exacerbations.

17 March 2025 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
MŞMerve Yumrukuz Şenel
Merve Yumrukuz Şenel
RŞRabia Şahin
Rabia Şahin
MÇMustafa Çolak
Mustafa Çolak
HÇHikmet Çoban
Hikmet Çoban
FEFuat Erel
Fuat Erel
NSNurhan Sarioglu
Nurhan Sarioglu

1 January 2020 in Polish Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
MÇMustafa Çolak
Mustafa Çolak
SKSerdar Kalemci
Serdar Kalemci
AAAylin Alpaydın
Aylin Alpaydın
VKVolkan Karaçam
Volkan Karaçam
IMIbrahim Meteoğlu
Ibrahim Meteoğlu
BIBahriye Itil
Bahriye Itil
Introduction Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are acute onset syndromes affecting the lungs, which develop for several reasons and are characterized by hypoxemia and diffuse lung infiltration. The activity of thymoquinone (TQ) is known in acute lung injury....

13 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GGGulcin Yilmaz Gunes
Gulcin Yilmaz Gunes
HÇHikmet Çoban
Hikmet Çoban
NSNurhan Sarioglu
Nurhan Sarioglu
FEFuat Erel
Fuat Erel
MAMerve Akis
Merve Akis
AHAdnan Adil Hismiogullari
Adnan Adil Hismiogullari
Objectives: Hepcidin is a biomarker produced by hepatocytes in chronic disease anemia and is known to increase during chronic inflammation. This study compares the hepcidin levels in idiopathic pulmonary fibrosis (IPF) patients and controls, evaluating its relationship with anemia and systemic inflammation in IPF patients. Methods: This study included 82 IPF patients and 31 controls. Hepcidin levels were compared between the two groups. In the IPF group, the hepcidin and anemia parameters were compared between anemic and non-anemic patients. The significance between the hepcidin and systemic inflammation parameters such as Erythrocyte Sedimentation Rate, CRP (C-reactive protein) levels, ferritin levels, and the Systemic Immune–Inflammation Index (SII) was investigated. Erythrocyte Sedimentation Rate, C-reactive protein (CRP) levels, and ferritin levels were measured using automated analyzers. Hepcidin and erythropoietin (EPO) levels were determined using ELISA kits. Results: A significant difference in hepcidin levels was found between the IPF and control groups (37.13 ± 14.92 vs. 25.77 ± 11.25, p < 0.001). No significant difference in hepcidin levels was found between anemic and non-anemic IPF patients (38.25 ± 16.2 vs. 36.7 ± 14.6, p = 0.719). No significant correlation was found between hepcidin levels and anemia parameters (serum iron, ferritin, vitamin B12, serum transferrin, transferrin saturation, total iron-binding capacity, hemoglobin, folate, and erythropoietin) in IPF patients. Despite significant differences in the systemic inflammation parameters (ferritin and CRP) between patients and controls, no significant correlation was found between their hepcidin and systemic inflammation parameters. Conclusions: Our study demonstrates that the hepcidin levels in IPF patients are elevated independently of anemia and systemic inflammation. We propose that hepcidin could be a potential biomarker to be investigated in IPF patients.

12 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NKNagihan Durmuş Koçak
Nagihan Durmuş Koçak
NTNuri Tutar
Nuri Tutar
GÇGizem Çil
Gizem Çil
EAEmine Afşin
Emine Afşin
AŞAyşegül Şentürk
Ayşegül Şentürk
APAyşe Pala
Ayşe Pala
Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274–0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365–0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.

1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MŞMerve Yumrukuz Şenel
Merve Yumrukuz Şenel
EAEmine Ayan
Emine Ayan
MÇMustafa Çolak
Mustafa Çolak
HÇHikmet Çoban
Hikmet Çoban
FEFuat Erel
Fuat Erel
NSNurhan Sarioglu
Nurhan Sarioglu
SUMMARY OBJECTIVE: The aim of this study was to determine the quality, reliability, and readability of the responses provided by artificial intelligence chatbots about idiopathic pulmonary fibrosis. METHODS: The clinically relevant questions about idiopathic pulmonary fibrosis diagnosis, treatment, prognosis, and lifestyle management were submitted to four widely used artificial intelligence chatbots, including ChatGPT, Perplexity, Gemini, and Copilot. Responses were assessed by five clinicians based on readability, understandability, quality, and content reliability using standardized tools. RESULTS: The overall readability of chatbot-generated responses was low, corresponding to high educational requirements. Understandability ranged from moderate to good, whereas actionability remained moderate. Gemini produced the most readable and understandable outputs. Journal of the American Medical Association and Likert scores indicated limited source transparency but good guideline concordance. DISCERN analysis for the treatment question showed significant variation (p=0.003), with Perplexity achieving the highest total score. CONCLUSION: Although artificial intelligence chatbots offer rapid and accessible information, their readability and source reliability remain limited. These findings highlight the necessity of expert supervision and further model improvement before artificial intelligence chatbots can be safely integrated into patient education.